BSE Live
Apr 06, 12:13Prev. Close
58.07
Open Price
63.87
Bid Price (Qty.)
55.01 (30)
Offer Price (Qty.)
60.50 (47)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Key Financial Ratios of Aspira Pathlab & Diagnostics (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -4.56 | -6.33 | -10.75 | -5.25 | 0.12 | |
| Diluted EPS (Rs.) | -4.95 | -7.41 | -10.75 | -8.12 | 0.12 | |
| Cash EPS (Rs.) | -2.78 | -4.83 | -8.58 | -4.86 | 0.13 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 4.09 | 6.34 | 0.64 | 11.39 | 16.17 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 4.09 | 6.34 | 0.64 | 11.39 | 16.17 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 9.06 | 9.32 | 8.39 | 1.46 | 0.00 | |
| PBDIT/Share (Rs.) | -1.66 | -3.65 | -7.03 | -4.37 | 0.40 | |
| PBIT/Share (Rs.) | -3.44 | -5.15 | -9.20 | -4.75 | 0.39 | |
| PBT/Share (Rs.) | -4.53 | -6.33 | -10.75 | -5.25 | 0.16 | |
| Net Profit/Share (Rs.) | -4.56 | -6.33 | -10.75 | -5.25 | 0.12 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | -18.29 | -39.20 | -83.82 | -298.85 | 0.00 | |
| PBIT Margin (%) | -38.02 | -55.28 | -109.63 | -325.14 | 0.00 | |
| PBT Margin (%) | -50.04 | -67.86 | -128.10 | -359.11 | 0.00 | |
| Net Profit Margin (%) | -50.38 | -67.86 | -128.10 | -359.08 | 0.00 | |
| Return on Networth / Equity (%) | -111.56 | -99.83 | -1,667.23 | -46.05 | 0.75 | |
| Return on Capital Employed (%) | -34.73 | -39.86 | -43.84 | -27.09 | 0.75 | |
| Return on Assets (%) | -29.58 | -35.02 | -44.54 | -18.33 | 0.43 | |
| Total Debt/Equity (X) | 1.81 | 1.30 | 31.62 | 1.15 | 0.72 | |
| Asset Turnover Ratio (%) | 58.71 | 51.60 | 34.77 | 5.10 | 0.00 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.64 | 0.55 | 1.09 | 0.69 | 2.16 | |
| Quick Ratio (X) | 0.59 | 0.48 | 0.87 | 0.67 | 2.16 | |
| Inventory Turnover Ratio (X) | 30.44 | 27.27 | 11.80 | 6.37 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 41.37 | 29.06 | 19.19 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 4.91 | 3.81 | 4.40 | 0.00 | 0.00 | |
| EV/EBITDA (X) | -26.87 | -9.71 | -5.25 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 4.23 | 2.93 | 2.02 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 9.36 | 4.32 | 26.37 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 4.23 | 2.93 | 2.02 | 0.00 | 0.00 | |
| Earnings Yield | -0.12 | -0.23 | -0.63 | 0.00 | 0.00 |
25.02.2026
Aspira Pathlab Standalone December 2025 Net Sales at Rs 5.12 crore, down 5.34% Y-o-Y
13.08.2025
Aspira Pathlab Consolidated June 2025 Net Sales at Rs 5.25 crore, up 13.17% Y-o-Y
19.05.2025
Aspira Pathlab Standalone March 2025 Net Sales at Rs 5.78 crore, up 51.31% Y-o-Y
10.02.2025
Aspira Pathlab Standalone December 2024 Net Sales at Rs 5.41 crore, up 56.21% Y-o-Y